MediCor to Present at the CIBC World Markets 17th Annual Healthcare Conference
November 03 2006 - 6:15AM
PR Newswire (US)
LAS VEGAS, Nov. 3 /PRNewswire-FirstCall/ -- MediCor Ltd. (OTC:MDCR)
(BULLETIN BOARD: MDCR) , a leading manufacturer and distributor of
breast implants worldwide, today announced that Theodore R.
Maloney, its Chief Executive Officer, will be presenting at the
CIBC World Markets 17th Annual Healthcare Conference on Tuesday,
November 7, 2006 at 1:50 p.m. Eastern Standard Time at the
Waldorf-Astoria Hotel in New York, NY. A copy of the slide
presentation will be available on the Company's website at the
commencement of the presentation and will be archived on the
Company's website for 30 days following the presentation. About
MediCor Ltd. MediCor was founded by Chairman of the Board Donald K.
McGhan, a pioneer of the breast implant industry. The Company
acquires, develops, manufactures and markets products for medical
specialties in the aesthetic, plastic and reconstructive surgery
and dermatology markets. Products include surgically implantable
prostheses for aesthetic, plastic and reconstructive surgery and
scar management products. Its products are sold worldwide to
hospitals, surgery centers and physicians through various
distributors and direct sales personnel. MediCor's strategy is to
be the leading integrator of selected international medical device
markets, technologies and businesses. To achieve this strategy,
MediCor intends to build upon and expand its business lines,
primarily in the aesthetic, plastic and reconstructive surgery and
dermatology markets. MediCor intends to both expand existing
product lines and offerings and acquire companies and other assets,
including intellectual property rights or distribution rights.
Forward-Looking Statements This release contains forward-looking
statements. Such statements are based upon the current beliefs and
expectations of MediCor's management and are subject to significant
risks and uncertainties. Actual results may differ from those set
forth in the forward-looking statements. The following factors,
among others, could cause actual results to differ from those set
forth in the forward-looking statements: our ability to sustain
continued losses and obtain requisite additional financing to
continue operations; the acceptability to regulators of our
regulatory data and submissions; the ability to obtain governmental
approvals to market our products; the timing of our and our
competitors' approvals and entry to markets; the effect of such
timing and the related delays in revenues and continued expenses
and their affect on our ability to successfully and profitably
operate our businesses; increased competition and its effect on
pricing, spending, third-party relationships and revenues; the risk
that businesses we acquire will not be integrated or operated
successfully; the risk that cost savings or other anticipated
benefits from acquisition transactions may not be realized or may
take longer to realize than expected; disruption from transactions
making it more difficult to maintain relationships with customers,
employees or suppliers; the outcome of legal proceedings; the risk
of new and changing regulations in the U.S. and internationally;
the risk of instability in the capital markets in the U.S. and
internationally; and the ability to effect acquisitions to continue
to execute on our growth plans. Additional factors that could cause
MediCor's results to differ materially from those described in the
forward-looking statements can be found in MediCor's Annual Report
on Form 10-K for the year ended June 30, 2006, subsequent quarterly
filings on Form 10-Q, and other announcements on Form 8- K, all of
which have been filed with the Securities and Exchange Commission
and are available at the Securities and Exchange Commission's
Internet site (http://www.sec.gov/). DATASOURCE: MediCor Ltd.
CONTACT: Marc S. Sperberg of MediCor Ltd., +1-702-932-4560, ext.
308 Web site: http://medicorltd.com/
Copyright